Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

[1]  Lin Guo.  Women's health in rural China , 2012 .

[2]  Y. Qiao,et al.  Cost‐effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high‐risk region of China , 2010, International journal of cancer.

[3]  J. Berkhof,et al.  Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test , 2010, British Journal of Cancer.

[4]  Y. Qiao,et al.  Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: Comparison of sensitivity, specificity, and frequency of referral , 2010, International journal of cancer.

[5]  P. Castle,et al.  Benefits and risks of HPV testing in cervical cancer screening. , 2010, The Lancet. Oncology.

[6]  J. Cuzick,et al.  Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. , 2010, The Lancet. Oncology.

[7]  Y. Qiao,et al.  Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection , 2009, International journal of cancer.

[8]  J. Sellors,et al.  Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acid , 2010, International journal of cancer.

[9]  Y. Qiao,et al.  [Perspective of cervical cancer prevention and control in developing countries and areas]. , 2010, Chinese journal of cancer.

[10]  J. Peto,et al.  Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial , 2009, Journal of Clinical Microbiology.

[11]  A. Anttila,et al.  Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. , 2009, Journal of the National Cancer Institute.

[12]  Jack Cuzick,et al.  How to evaluate emerging technologies in cervical cancer screening? , 2009, International journal of cancer.

[13]  G. Ronco,et al.  Trials comparing cytology with human papillomavirus screening. , 2009, The Lancet. Oncology.

[14]  K. Lakshmaiah,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[15]  Henry C Kitchener,et al.  HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. , 2009, The Lancet. Oncology.

[16]  C. Wheeler,et al.  Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2 , 2009, Obstetrics and gynecology.

[17]  Joakim Dillner,et al.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study , 2008, BMJ : British Medical Journal.

[18]  Feng Chen,et al.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. , 2008, The Lancet. Oncology.

[19]  S. Franceschi,et al.  Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. , 2008, Vaccine.

[20]  Marc Arbyn,et al.  Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India , 2008, International journal of cancer.

[21]  J. Cuzick,et al.  Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. , 2008, Journal of the National Cancer Institute.

[22]  S. Franceschi,et al.  Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study , 2006, British Journal of Cancer.

[23]  J. Cuzick,et al.  Overview of the European and North American studies on HPV testing in primary cervical cancer screening , 2006, International journal of cancer.

[24]  F. Bray,et al.  Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.

[25]  J. Dillner,et al.  Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. , 2006, Vaccine.

[26]  Javier Zamora,et al.  Meta-DiSc : a software for meta-analysis of test accuracy data , 2015 .

[27]  S. Franceschi,et al.  Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study , 2006, British Journal of Cancer.

[28]  Y. Qiao,et al.  Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy , 2006, Journal of lower genital tract disease.

[29]  Y. Qiao,et al.  Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. , 2004, American journal of obstetrics and gynecology.

[30]  J. T. Cox,et al.  Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening , 2004, Obstetrics and gynecology.

[31]  Y. Qiao,et al.  Shanxi Province cervical cancer screening study II: Self‐sampling for high‐risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[32]  M. Plummer,et al.  Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. , 2003, American journal of epidemiology.

[33]  Siwei Zhang,et al.  [Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China]. , 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[34]  Y. Qiao,et al.  A Thin-Layer, Liquid-Based Pap Test for Mass Screening in an Area of China with a High Incidence of Cervical Carcinoma , 2003, Acta Cytologica.

[35]  Shalini L Kulasingam,et al.  Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. , 2002, JAMA.

[36]  Y. Qiao,et al.  Primary Screening with Liquid-Based Cytology in an Unscreened Population in Rural China, with an Emphasis on Reprocessing Unsatisfactory Samples , 2002, Acta Cytologica.

[37]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[38]  Stephen S Raab,et al.  Cervical cancer screening by simple visual inspection after acetic acid. , 2002, Obstetrics and gynecology.

[39]  Y. Qiao,et al.  Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. , 2001, Gynecologic oncology.